Odevixibat — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-06-22 today
ESTIMATED |
READOUT
Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Unde
Phase 3 · Biliary Atresia |
Albireo, an Ipsen Company | Odevixibat |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|